Title:
CIIP Brazil - CANNABIS-PHARMA - Advancing Cannabis Biotechnology: Stable CBG-Rich Polyploid Cultivars for Anti-Inflammatory and Analgesic Applications
Agreement Number:
1039500
Agreement Value:
$600,000.00
Agreement Date:
Feb 1, 2026 - Jan 31, 2028
Description:
As part of the international consortium project “CANNABIS-PHARMA”, the project aims to select and investigate cannabigerol-enriched cannabis plants that have anti-inflammatory and analgesic therapeutic value, using polyploidy and molecular fingerprinting technologies.
Organization:
National Research Council Canada
Expected Results:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Location:
Richmond, British Columbia, CA V6W 1M2
Reference Number:
172-2025-2026-Q4-1039500
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
719224925
Recipient Type:
For-profit organization
Recipient's Operating Name:
Segra International
Recipient's Legal Name:
SEGRA INTERNATIONAL CORP.
Federal Riding Name:
Steveston--Richmond East
Federal Riding Number:
59031
Program:
Canadian International Innovation Program
Program Purpose:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Coverage:
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access.